Summary
The present study was undertaken to assess the effect of prazosin, a selective postsynaptic α1-adrenergic receptor blocking agent, on normoxic and hypoxic mice, in order to evaluate experimentally its use in the treatment of the excessive erythrocytosis that characterizes chronic mountain sickness. The drug, injected intraperitoneally to adult mice at a dose of 400 μg/kg per day, induced a significant depression of the rate or eryhtropoiesis, as measured by red blood cell59iron uptake, with a decrease in the hematocrit from the 3rd day. The drug also inhibited the oxygen-dependent secretion of erythropoietin (estimated by the plasma immunoreactive hormone concentration) in hypoxemic mice when injected between 0 and 2 h after initiation of the hypoxic stimulation. When injected daily into mice exposed to intermittent hypobaric hypoxia, prazosin limited the degree of polycythemia or induced a sustained decrease in the hematocrit when polycythemia was already present due to previous exposure. It is postulated that the drug, by reducing the peripheral vascular resistance seen during hypoxia, could increase renal blood flow, thus improving the renal oxygen supply and partially restoring the imbalance between gas supply and demand, which drives erythropoietin formation.
Similar content being viewed by others
References
Winslow RM, Monge CC. Hypoxia, polycythemia, and chronic mountain sickness. Baltimore: The John Hopkins University Press, 1987.
Kryger M, McCullough RE, Collins DO, Scoggin CM, Wie JV, Grouer RF. Treatment of excessive polycythemia of high altitude with respiratory stimulant drugs. Rev Respir Dis 1978; 117:455.
Kryger M, Glas R, Jackson D, McCullough RE, Scoggin C, Grouer RF, Weil JV. Impaired oxygenation during sleep in excessive polycythemia of high altitude: improvement with respiratory stimulation. Sleep 1978; 1:3.
Villena M, Vargas E, Guenard HK, Nallar N, Tellez W, Spielvogel H. Etude en double insu de l'effect de l'almitrine sur les malades porteours de poliglobulie pathologique d'altitude. Clin Respir Physiol 1985; 21:165.
Leòn-Velarde F, Monge CC, Vidal A, Carcagno M, Criscuolo M, Bozzini CE. Serum immunoreactive erythropoietin in high altitude natives with and without excessive erythrocytosis. Exp Hematol 1991; 19:257.
Fink GD, Fisher JW. Role of the sympathetic nervous system in the control of erythropoietin production. In: Fisher JW, ed. Kidney hormones, vol. II. Erythropoietin. London: Academic Press; 1977: 387–413.
Wright BM. Apparatus for exposing animals to reduced atmosphere pressure for long periods. Br J Haematol 1964; 10:75.
Powell VS, Berkner KL, Lebo RV, Adamson V. Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization. Proc Natl Acad Sci USA 1986; 83:6465.
Tambourin PE, Wending F, Gallien-Lartigue O, Huaulme D. Production of high plasma levels of erythropoietin in mice. Biomedicine 1973; 19:112.
Paz A. Un modelo de hipoxia intermitente en ratones: consumo de oxigeno, eliminaciòn de anhidrido carbònico y cociente respiratorio (thesis). UPCH, 1976.
Fried W, Plzak LF, Jacobson LO, Goldwasser E. Studies on erythropoiesis. III. Factors controlling erythropoietin production. Proc Soc Exp Biol Med 1957; 94:237.
Koury MJ, Bondurant MC. The molecular mechanism of erythropoietin action. Eur J Biochem 1992; 210:649.
Ratcliffe PJ, Jones RW, Phillips RE, Nicholls LG, Bell JI. Oxygen-dependent modulation of erythropoietin mRNA levels in isolated rat kidneys studied by RNase protection. J Exp Med 1990; 172:657.
Heistad DD, Abboud FM. Circulatory adjustments to hypoxia. Circulation 1980; 61:463.
Meehan RT, Zavala DC. The pathophysiology of acute high-altitude illness. Am J Med 1982; 73:395.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Izaguirre, V., Vargas, M., León-Velarde, F. et al. Inhibitory effect of an α1-adrenergic antagonist on erythropoiesis in normoxic or hypoxic miceantagonist on erythropoiesis in normoxic or hypoxic mice. Int J Clin Lab Res 24, 213–216 (1994). https://doi.org/10.1007/BF02592465
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02592465